Tuberculosis and mass gatherings—opportunities for defining burden, transmission risk, and the optimal surveillance, prevention, and control measures at the annual Hajj pilgrimage

International Journal of Infectious Diseases

Volumn 47, Issue , 2016, Pages 86-91

  Zumla, Alimuddin ^a,c,d,e,f   Saeed, Abdulaziz Bin ^b,c   Alotaibi, Badriah ^c   Yezli, Saber ^c   Dar, Osman ^d   Bieh, Kingsley ^c   Bates, Matthew ^a,e   Tayeb, Tamara ^c   Mwaba, Peter ^e   Shafi, Shuja ^c,g   McCloskey, Brian ^c,d   Petersen, Eskild ^c,h,i   Azhar, Esam I ^c,f  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c MINISTRY OF HEALTH   (Saudi Arabia)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e UNIVERSITY OF ZAMBIA   (Zambia)

^f KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^g MUSLIM COUNCIL OF GREAT BRITAIN   (United Kingdom)

^h ROYAL HOSPITAL   (Oman)

ⁱ AARHUS UNIVERSITY   (Denmark)

Author keywords

Hajj; Mass gatherings; Transmission; Tuberculosis

Indexed keywords

ARTICLE; DISEASE TRANSMISSION; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; INFECTION RISK; LATENT TUBERCULOSIS; MEDICAL RESEARCH; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; RESEARCH PRIORITY; TUBERCULOSIS; CROWDING (AREA); EPIDEMIOLOGICAL MONITORING; FEMALE; ISLAM; LEISURE; MALE; RISK FACTOR; SAUDI ARABIA; TRANSMISSION; TRAVEL;

CROWDING; EPIDEMIOLOGICAL MONITORING; FEMALE; HOLIDAYS; HUMANS; ISLAM; MALE; RISK FACTORS; SAUDI ARABIA; TRAVEL; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84959449509     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2016.02.003     Document Type: Article

References (48)

1. WHO TB: a global emergency, Geneva: World Health Organization; 1994. WHO/TB/94.177. http://apps.who.int/iris/bitstream/10665/58749/1/WHO_TB_94.177.pdf (accessed January 26, 2016).
2. World Health Organization. WHO Global Report on Tuberculosis 2015. Geneva: WHO; 2015. Available at: http://who.int/tb/publications/global_report/en/ (accessed December 28, 2015).
3. United Nations. New York: UN; 2015. Available at: http://www.un.org/millenniumgoals/bkgd.shtml (accessed December 28, 2015).
4. World Health Organization. WHO global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva: WHO; 2015. Available at: http://www.who.int/tb/post2015_tbstrategy.pdf?ua=1 (accessed December 26, 2016).
5. Driver, C.R., Valway, S.E., Morgan, W.M., Onorato, I.M., Castro, K.G., Transmission of Mycobacterium tuberculosis associated with air travel. JAMA 272 (1994), 1031–1035.
6. Abubakar, I., Tuberculosis and air travel: a systematic review and analysis of policy. Lancet Infect Dis 10 (2010), 176–183.
7. Al-Jahdali, H., Memish, Z.A., Menzies, D., Tuberculosis in association with travel. Int J Antimicrob Agents 21 (2003), 125–130.
8. Al-Bishri, J., Masoodi, I., Adnan, M., Tariq, M., Abdullah, H., Abdulgoni, T., et al. Population dynamics and tuberculosis: a cross sectional study of an overlooked disease in Saudi Arabia. Ger Med Sci, 12, 2014, Doc02, 10.3205/000187.
9. Smallwood, C.A., Arbuthnott, K.G., Banczak-Mysiak, B., Borodina, M., Coutinho, A.P., Payne-Hallström, L., et al. Euro 2012 European Football Championship Finals: planning for a health legacy. Lancet 383 (2014), 2090–2097.
10. McCloskey, B., Endericks, T., Catchpole, M., Zambon, M., McLauchlin, J., Shetty, N., et al. London 2012 Olympic and Paralympic Games: public health surveillance and epidemiology. Lancet 383 (2014), 2083–2089.
11. Memish, Z.A., Zumla, A., Alhakeem, R.F., Assiri, A., Turkestani, A., Al Harby, K.D., et al. Hajj: infectious disease surveillance and control. Lancet 383 (2014), 2073–2082.
12. Zumla, A., Hui, D.S., Al-Tawfiq, J.A., Gautret, P., McCloskey, B., Memish, Z.A., Emerging respiratory tract infections. Lancet Infect Dis 14 (2014), 910–911.
13. Al-Orainey, I.O., Tuberculosis infection during Hajj pilgrimage. The risk to pilgrims and their communities. Saudi Med J 34 (2013), 676–680.
14. Lai, K.M., Bottomley, C., McNerney, R., Propagation of respiratory aerosols by the vuvuzela. PLoS One, 6, 2011, e20086, 10.1371/journal.pone.0020086.
15. Mantero, J., Szegedi, E., Payne Hallstrom, L., Lenglet, A., Depoortere, E., Kaic, B., et al. Enhanced epidemic intelligence using a web-based screening system during the 2010 FIFA World Cup in South Africa. Euro Surveill, 19, 2014 pii: 20796.
16. Memish, Z.A., Zumla, A., McCloskey, B., Heymann, D., Al Rabeeah, A.A., Barbeschi, M., et al. Mass gatherings medicine: international cooperation and progress. Lancet 383 (2014), 2030–2032.
17. Al Rabeeah, A., Memish, Z.A., Zumla, A., Shafi, S., McCloskey, B., Moolla, A., et al. Mass gatherings medicine and global health security. Lancet 380 (2012), 3–4, 10.1016/S0140-6736(12)61073-3.
18. Zumla, A., Al-Tawfiq, J.A., Enne, V.I., Kidd, M., Drosten, C., Breuer, J., et al. Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects. Lancet Infect Dis 14 (2014), 1123–1135.
19. Schito, M., Migliori, G.B., Fletcher, H.A., McNerney, R., Centis, R., D'Ambrosio, L., et al. Perspectives on advances in tuberculosis diagnostics, drugs, and vaccines. Clin Infect Dis 61:Suppl 3 (2015), S102–S118.
20. Abouzeid, M.S., Zumla, A.I., Felemban, S., Alotaibi, B., O'Grady, J., Memish, Z.A., Tuberculosis trends in Saudis and non-Saudis in the Kingdom of Saudi Arabia—a 10 year retrospective study (2000–2009). PLoS One, 7, 2012, e39478.
21. Al-Hajoj, S., Varghese, B., Shoukri, M.M., Al-Omari, R., Al-Herbwai, M., Alrabiah, F., et al. Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey. Antimicrob Agents Chemother 57 (2013), 2161–2166.
22. Al-Tawfiq, J.A., Hinedi, K., Memish, Z.A., Systematic review of the prevalence of Mycobacterium tuberculosis resistance in Saudi Arabia. J Chemother 27 (2015), 378–382.
23. Varghese, B., Supply, P., Allix-Béguec, C., Shoukri, M., Al-Omari, R., Herbawi, M., et al. Admixed phylogenetic distribution of drug resistant Mycobacterium tuberculosis in Saudi Arabia. PLoS One, 8, 2013, e55598, 10.1371/journal.pone.0055598.
24. Alzeer, A.H., Respiratory tract infection during Hajj. Ann Thorac Med 4 (2009), 50–53.
25. Al-Tawfiq, J.A., Zumla, A., Memish, Z.A., Respiratory tract infections during the annual Hajj: potential risks and mitigation strategies. Curr Opin Pulm Med 19 (2013), 192–197.
26. Memish, Z.A., Assiri, A., Turkestani, A., Yezli, S., Al Masri, M., Charrel, R., et al. Mass gathering and globalization of respiratory pathogens during the 2013 Hajj. Clin Microbiol Infect, 21, 2015, 10.1016/j.cmi.2015.02.008 571.e1–8.
27. Zumla, A., Memish, Z.A., Maeurer, M., Bates, M., Mwaba, P., Al-Tawfiq, J.A., et al. Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options. Lancet Infect Dis 14 (2014), 1136–1149.
28. Benkouiten, S., Charrel, R., Belhouchat, K., Drali, T., Salez, N., Nougairede, A., et al. Circulation of respiratory viruses among pilgrims during the 2012 Hajj pilgrimage. Clin Infect Dis, 57, 2013, 992.
29. Rashid, H., Shafi, S., Haworth, E., El Bashir, H., Memish, Z.A., Sudhanva, M., et al. Viral respiratory infections at the Hajj: comparison between UK and Saudi pilgrims. Clin Microbiol Infect 14 (2008), 569–574.
30. Gautret, P., Benkouiten, S., Griffiths, K., Sridhar, S., The inevitable Hajj cough: surveillance data in French pilgrims, 2012-2014. Travel Med Infect Dis 13 (2015), 485–489.
31. Kholeidi, A.N., Baksh, M.F., AlHamad, N.A., Al Mazam, A.A., Mohammed, A.G., Ghazi, H., Seropositivity in clinical influenza cases among pilgrims during Hajj, 1421 H (2001). Saudi Epidemiol Bull 8 (2001), 27–28.
32. Balkhy, H.H., Memish, Z.A., Bafaqeer, S., Almuneef, M.A., Influenza a common viral infection among Hajj pilgrims: time for routine surveillance and vaccination. J Travel Med 11 (2004), 82–86.
33. Rashid, H., Shafi, S., Booy, R., El Bashir, H., Ali, K., Zambon, M.C., et al. Influenza and respiratory syncytial virus infections in British Hajj pilgrims. Emerg Health Threats J, 1, 2008, e2.
34. Gautret, P., Parola, P., Brouqui, P., Relative risk for influenza like illness in French Hajj pilgrims compared to non-Hajj attending controls during the 2009 influenza pandemic. Travel Med Infect Dis, 11, 2013, 9.
35. Al-Asmary, S., Al-Shehri, A.S., Abou-Zeid, A., Abdel-Fattah, M., Hifnawy, T., El-Said, T., Acute respiratory tract infections among Hajj medical mission personnel, Saudi Arabia. Int J Infect Dis 11 (2007), 268–272.
36. al-Kassimi, F.A., Abdullah, A.K., Al-Hajjaj, M.S., Al-Orainey, I.O., Bamgboye, E.A., Chowdhury, M.N., Nationwide community survey of tuberculosis epidemiology in Saudi Arabia. Tuber Lung Dis 74 (1993), 254–260.
37. Alzeer, A., Mashlah, A., Fakim, N., Al-Sugair, N., Al-Hedaithy, M., Al-Majed, S., et al. Tuberculosis is the commonest cause of pneumonia requiring hospitalization during Hajj (pilgrimage to Makkah). J Infect 36 (1998), 303–306.
38. Zumla, A., Atun, R., Maeurer, M., Mwaba, P., Ma, Z., O'Grady, J., et al. Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection. Trop Med Int Health 16 (2011), 79–83.
39. Madani, T.A., Ghabrah, T.M., Al-Hedaithy, M.A., Alhazmi, M.A., Alazraqi, T.A., Albarrak, A.M., et al. Causes of hospitalization of pilgrims in the Hajj season of the Islamic year 1423 (2003). Ann Saudi Med 26 (2006), 346–351.
40. Mandourah, Y., Al-Radi, A., Ocheltree, A.H., Ocheltree, S.R., Fowler, R.A., Clinical and temporal patterns of severe pneumonia causing critical illness during Hajj. BMC Infect Dis, 12, 2012 117.1–8.
41. Wilder-Smith, A., Foo, W., Earnest, A., Paton, N.I., High risk of Mycobacterium tuberculosis infection during the Hajj pilgrimage. Trop Med Int Health 10 (2005), 336–339.
42. Bates, M., O'Grady, J., Mwaba, P., Chilukutu, L., Mzyece, J., Cheelo, B., et al. Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients. PLoS One, 7, 2012, e40774, 10.1371/journal.pone.0040774.
43. Lawn, S.D., Mwaba, P., Bates, M., Piatek, A., Alexander, H., Marais, B.J., et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 13 (2013), 349–361.
44. Al-Hajoj, S.A., Mohammed, V.K., Al-Hokail, A.A., Usefulness of molecular techniques to identify ongoing tuberculosis transmission in Saudi Arabia. Saudi Med J 28 (2007), 268–270.
45. Al-Hajoj, S., Varghese, B., Tuberculosis in Saudi Arabia: the journey across time. J Infect Dev Ctries 9 (2015), 222–231.
46. Pankhurst, L.J., Del Ojo Elias, C., Votintseva, A.A., Walker, T.M., Cole, K., Davies, J., et al. Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study. Lancet Respir Med 4 (2016), 49–58.
47. Colijn, C., Cohen, T., Whole-genome sequencing of Mycobacterium tuberculosis for rapid diagnostics and beyond. Lancet Respir Med 4 (2016), 6–8.
48. Khan, N.A., Ishag, A.M., Ahmad, M.S., El-Sayed, F.M., Bachal, Z.A., Abbas, T.G., Pattern of medical diseases and determinants of prognosis of hospitalization during 2005 Muslim pilgrimage Hajj in a tertiary care hospital. A prospective cohort study. Saudi Med J 27 (2006), 1373–1376.